文献速递肝病

遗传关联分析识别与原发性硬化性胆管炎疾病进展相关的变异

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
PubMed 文献 · Gut · 2017-08-04

在3402例原发性硬化性胆管炎(PSC)患者中,利用免疫芯片的130422个单核苷酸多态性分析其与疾病亚表型的关联。发现遗传变异rs853974与无肝移植生存相关(p=6.07×10-9),AA纯合携带者10年无移植生存率为50.9%(95%CI 41.5%~59.5%),GG携带者为72.8%(95%CI 69.6%~75.7%)。候选基因RSPO3在人类和小鼠胆管细胞及人肝星状细胞中表达。

要点

  • rs853974与PSC无肝移植生存相关(p=6.07×10-9)。
  • rs853974 AA纯合携带者10年无移植生存率50.9%,GG携带者72.8%。
  • 候选基因RSPO3表达于人类和小鼠胆管细胞及人肝星状细胞。

核心结论

  • 报告了与PSC疾病进展相关的遗传位点,rs853974与无肝移植生存达全基因组显著关联,候选基因RSPO3在关键肝驻留效应细胞中表达,需进一步评估该潜在PSC修饰基因的作用。

研究设计与样本

  • 在3402例PSC患者的大型队列中收集标准化PSC亚表型,经质量控制后,将患者Illumina免疫芯片获得的130422个单核苷酸多态性与疾病亚表型合并分析。
  • 使用逻辑回归和Cox比例风险模型识别与二分类及时间-事件PSC亚表型相关的遗传变异。

主要发现

  • 识别出遗传变异rs853974与无肝移植生存相关(p=6.07×10-9)。
  • Kaplan-Meier生存分析显示,PSC诊断后10年,rs853974 AA纯合携带者无移植生存率为50.9%(95%CI 41.5%~59.5%),GG携带者为72.8%(95%CI 69.6%~75.7%)。
  • 候选基因RSPO3在人类和小鼠胆管细胞及人肝星状细胞等关键肝驻留效应细胞中表达。

局限性

  • 原文结论指出需进一步评估该潜在关键PSC修饰基因的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Primary sclerosing cholangitis (PSC) is a genetically complex, inflammatory bile duct disease of largely unknown aetiology often leading to liver transplantation or death. Little is known about the genetic contribution to the severity and progression of PSC. The aim of this study is to identify genetic variants associated with PSC disease progression and development of complications. DESIGN: We collected standardised PSC subphenotypes in a large cohort of 3402 patients with PSC. After quality control, we combined 130 422 single nucleotide polymorphisms of all patients-obtained using the Illumina immunochip-with their disease subphenotypes. Using logistic regression and Cox proportional hazards models, we identified genetic variants associated with binary and time-to-event PSC subphenotypes. RESULTS: We identified genetic variant rs853974 to be associated with liver transplant-free survival (p=6.07×10-9). Kaplan-Meier survival analysis showed a 50.9% (95% CI 41.5% to 59.5%) transplant-free survival for homozygous AA allele carriers of rs853974 compared with 72.8% (95% CI 69.6% to 75.7%) for GG carriers at 10 years after PSC diagnosis. For the candidate gene in the region, RSPO3, we demonstrated expression in key liver-resident effector cells, such as human and murine cholangiocytes and human hepatic stellate cells. CONCLUSION: We present a large international PSC cohort, and report genetic loci associated with PSC disease progression. For liver transplant-free survival, we identified a genome-wide significant signal and demonstrated expression of the candidate gene RSPO3 in key liver-resident effector cells. This warrants further assessments of the role of this potential key PSC modifier gene.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Alberts R, de Vries EMG, Goode EC, et al. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis. Gut. 2017. PMID: 28779025. doi:10.1136/gutjnl-2016-313598

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。